M
MetaVia Inc. Common StockMTVA
MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing DA-1726 for the treatment of obesity, and is developing vanoglipel (DA-1241) for the treatment of Metabolic Dysfunction-Associated Steatohepatitis.
US StocksHealthcareSmall CapBiotechnology
MTVA の価格トレンド
MetaVia Inc. Common Stock · TradingView フルチャート
NASDAQ:MTVA